_Easy-Resize.com%20(1).avif)
Planning and Executing Your Exit as an Investor
Dr. Irit Yaniv, Founding Partner and CEO at Almeda Ventures (TLV: AMDA)
While most investors have a passive role in their portfolio company, some investors are active in shaping and contributing to its success. For venture capitalists, one of the best scenarios is for the portfolio company to be acquired to maximize investment returns.
In this episode of the M&A Science Podcast, Dr. Irit Yaniv, Founding Partner and CEO at Almeda Ventures discusses how to plan for sell side M&A as an investor.
Things you will learn:
- Preparing for sell side M&A
- Role as an investor
- Best advice for sell side M&A
- Managing exit planning disagreements
- Who controls exit decisions
.avif)
Almeda Ventures is a pioneering HealthTech-focused public R&D partnership that invests globally in medical devices, digital health, and bio-convergence. By leveraging its team’s deep expertise, diverse backgrounds, and extensive network with investors, strategics, and medical centers worldwide, Almeda Ventures helps portfolio companies thrive. They seek exceptional teams with innovative solutions that address major unmet needs, supported by proven clinical concepts and business models. Almeda Ventures drives the success of medical device and digital health companies through their extensive network and proven track record.
_Easy-Resize.com.avif)
Dr. Irit Yaniv
Dr. Irit Yaniv is the Founding Partner and CEO of Almeda Ventures, a public venture fund traded on the Tel Aviv Stock Exchange, focused on investments in medical devices, digital health, and bioconversion. With 15 years of increasing responsibilities in the life sciences industry, Dr. Yaniv has a robust background in managing product development from inception through launch, designing and implementing clinical studies, achieving FDA regulatory approvals, and driving sales growth. As an investor, she has led several companies through successful M&A transactions and continues to seek strategic acquisitions within Almeda's portfolio.
Recent M&A Science Podcast Episodes
M&A Software for optimizing the M&A lifecycle- pipeline to diligence to integration
Explore dealroom
Want to wear your M&A expertise?
Check out the M&A Science store.